Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Krstić, Miodrag (35341982900)"

Filter results by typing the first few letters
Now showing 1 - 7 of 7
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Epidemiological trends in stomach-related diseases
    (2014)
    Milosavljević, Tomica (7003788952)
    ;
    Kostić-Milosavljević, Mirjana (6505624886)
    ;
    Krstić, Miodrag (35341982900)
    ;
    Sokić-Milutinović, Aleksandra (55956752600)
    Epidemiology is a study of disease variations by geography, population demographics and time. Temporal influences can manifest themselves as age effects, period effects, cohort effects, seasonal or monthly variations. The acquisition of Helicobacter pylori infection during early childhood and the ensuing risk for the future development of peptic ulcer or gastric cancer represents a typical example for a cohort effect in digestive diseases. The incidence and prevalence of uncomplicated peptic ulcer have decreased in recent years, largely because of the availability of treatment to eradicate H. Pylori and the decreasing prevalence of H. Pylori infection. Nowadays, gastric and duodenal ulcers tend to occur in older people, who were more likely to have been exposed to H. Pylori in their childhood than recently born generations. The overall incidence of gastric cancers is declining; however, there has been a relative increase in the incidence of tumors of the esophagogastric junction and gastric cardia. Thus, by extrapolating the strong, stable and consistent mortality rate declines in recent decades, gastric cancer was projected to become increasingly less important as a cause of death in Europe in the next decades. © 2014 S. Karger AG, Basel.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Melena as a first sign of metastatic hepatic angiosarcoma: A case report; [Melena kao prvi znak metastatskog angiosarkoma jetre]
    (2019)
    Sokić-Milutinović, Aleksandra (55956752600)
    ;
    Tončev, Ljubiša (56023913400)
    ;
    Glišić, Tijana (7801650637)
    ;
    Matović, Vera (57193242761)
    ;
    Micev, Marjan (7003864533)
    ;
    Djuranović, Srdjan (6506242160)
    ;
    Krstić, Miodrag (35341982900)
    Introduction. Angiosarcomas are malignant tumors of vascular endothelium that may arise from different locations. Although primary hepatic angiosarcoma accounts for only 1.8% of primary liver tumors, it is the most common malignant mesenchymal tumor of the liver. We report a case of primary hepatic angiosarcoma with melena as an unusual initial manifestation of this extremely rare tumor. Case report. Forty-four-years old patient with melena was referred to our Clinic because melena was not resolved after repeated argon plasma coagulation of bleeding lesions during esophagogastroduodenoscopy in the regional hospital. Abdominal ultrasound and multislice computed tomography (MSCT) revealed enlarged liver, with focal lesion 6 cm in diameter localized in the left lobe with multiple satellite lesions in both liver lobes, enlarged spleen and extremely dilated and long umbilical vein. Double-balloon enteroscopy and video capsule endoscopy detected the multiple bleeding vascular lesions in the small bowel. Histopathological examination and immunohistochemistry of the small bowel lesions revealed malignant mesenchymal proliferation with vascular/endothelium differentiation of neoplastic cells. The patient was diagnosed with metastatic angiosarcoma probably of hepatic origin with metastasis in the small bowel, that caused melena, and in the lumbar spine, causing back pain. Conclusion. Rare causes of melena include bleeding from primary or metastatic hemangiosarcoma localized in the gastrointestinal tract, especially small bowel. © 2019, Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Portal hypertension caused by postoperative superior mesenteric arteriovenous fistula; [Portna hipertenzija prouzrokovana gornjom mezenteričnom arteriovenskom fistulom]
    (2012)
    Popović, Dušan Dj (37028828200)
    ;
    Špuran, Milan (6505943315)
    ;
    Davidović, Lazar (7006821504)
    ;
    Alempijević, Tamara (15126707900)
    ;
    Uglješić, Milenko (6701730451)
    ;
    Banzić, Igor (36518108700)
    ;
    Jadranin, Dragica (6507131431)
    ;
    Kovačević, Nada (7006810325)
    ;
    Perišić, Mirjana (7003479830)
    ;
    Čolić, Momčilo (7005003692)
    ;
    Krstić, Miodrag (35341982900)
    Introduction. Arteriovenous fistula of the superior mesenteric blood vessels is a rare complicaton in abdominal surgery. Case report. We presented a 49-year-old man with cramplike abdominal pain, abdominal distension and weight loss symptoms, with a history of previous small bowel resection and right colectomy, due to Crohn disease, 16 years ago. Clinical examination revealed a paraumbilical pulsation with systolic murmur and thrill. Ultrasonography and computed tomography revealed cystic dilatation of the superior mesenteric vein, hepatomegaly and ascites. Upper endoscopy revealed grade I esophageal varices with portal hypertensive gastropathy. The diagnosis of arteriovenous fistula between superior mesenteric artery and vein was confirmed by angiogram of the superior mesenteric vessels and resection of the fistula was performed. Control examination after nine months showed no signs of portal hypertension. Conclusion. Early diagnosis and treatment of mesenteric blood vessel arteriovenous fistula prevents portal hypertension development and its complications.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Quality of life in patients with chronic liver disease; [Kvalitet života bolesnika sa hroničnom bolešću jetre]
    (2018)
    Popović, Dušan Dj. (37028828200)
    ;
    Tepavčević, Darija Kisić (57218390033)
    ;
    Kovačević, Nada (7006810325)
    ;
    Milovanović, Tamara (55695651200)
    ;
    Krstić, Miodrag (35341982900)
    ;
    Ranković, Ivan (57192091879)
    ;
    Martinov, Jelena (16230832200)
    ;
    Glišić, Tijana (7801650637)
    ;
    Ješić, Rada (6701488512)
    ;
    Pekmezović, Tatjana (7003989932)
    Background/Aim. Quality of life is impaired in patients with the chronic liver disease (CLD). Patients with this disease have numerous disabling problems which lead to a reduced health related quality of life (HRQoL). The aim of our study was to evaluate the predictive value of selected socio-demographic and clinical characteristics on HRQoL in Serbian cohort of patients with the CLD. Methods. Over a period of one year, we performed a study which included patients with the CLD. We used Short Form Health Survay-36 (SF-36) for assessment of HRQoL. The assessment of depression and anxiety was made by using Hamilton scale of depression and anxiety, while the assessment of fatigue was performed by Fatigue severity scale. Results. The study included 103 patients with the CLD. The average values of the overall SF-36 scores were 52.6 ± 20.4, while the mean score of the composite scores were 53.5 ± 19.6 for the Mental component summary and 49.8 ± 21.3 for the Physical component summary. Some domains of HRQoL were significantly affected by following factors: gender, age, employment status, alcohol consumption, depression, anxiety and fatigue. Predictors of physical components of HRQoL were employment, depression and fatigue, and predictors of mental components were depression and fatigue. Conclusion. The tested socio-demographic, clinical and behavioral factors have an impact on the HRQoL in patients with the CLD. The most important predictors of HRQoL are behavioral factors suggesting the need for an adequate therapeutic action in order to improve the HRQoL in these patients. © 2018, Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Transient elastography for noninvasive assessment of liver fibrosis in patients with primary biliary cirrhosis; [Tranzijentna elastografija u neinvazivnoj proceni fibroze jetre kod bolesnika sa primarnom bilijarnom cirozom]
    (2018)
    Milovanović, Tamara (55695651200)
    ;
    Copertino, Ana (57202435419)
    ;
    Boričić, Ivan (6603959716)
    ;
    Miličić, Biljana (6603829143)
    ;
    Marković, Aleksandra Pavlović (24438035400)
    ;
    Krstić, Miodrag (35341982900)
    ;
    Matović, Vera (57193242761)
    ;
    Popović, Dušan Dj. (37028828200)
    Backgrund/Aim. In recent decades noninvasive methods for the assessment and monitoring of liver fibrosis have been developed and evaluated in numerous chronic liver diseases. The aim of this study was to evaluate the diagnostic accuracy of noninvasive markers for fibrosis assessment transient elastography (TE) and biochemical markers using liver biopsy as reference in patients with primary biliary cirrhosis (PBC). Methods. One hundred and twenty-two patients underwent both liver biopsy and blood tests on the same day and TE in a month following the biopsy and the tests. Liver biopsies were reviewed by a single pathologist using the METAVIR scoring system for assessment of liver fibrosis. Aspartate aminotransferase (AST), platelet ratio index (APRI), Forns scores, AST and alanine transaminase (ALT) ratio and TE were compared with liver fibrosis stage in order to determine the best noninvasive marker of liver fibrosis. Results. There was a statistically significant difference (p < 0.05) for the APRI score, Forns index and TE according to stages of liver fibrosis. TE showed superior diagnostic performance when compared to other surrogate markers of liver fibrosis that were investigated. Optimal cut-off for TE were 4.25 and 5.9 kPa for diagnosing the presence of fibrosis and distinguishing mild/moderate and advanced stages of fibrosis respectively. The areas under the receiver operating characteristic (AUROC) of TE were 0.963 and 0.865, respectively. Conclusion. Based on our investigation the APRI score, Forns index and TE adequately predict fibrosis stage in patients with primary biliary cirrhosis, but the most sensitive and specific parameter appears to be TE. Using noninvasive markers and methods in the evaluation of patients in daily clinical practice may reduce, but not eliminate, the need for invasive diagnostic procedures. © 2018, Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Ultrasound measurement of visceral fat in patients with primary biliary cirrhosis; [Ultrasonografsko merenje visceralne masti kod bolesnika sa primarnom bilijarnom cirozom]
    (2011)
    Alempijević, Tamara (15126707900)
    ;
    Ješić, Rada (6701488512)
    ;
    Svorcan, Petar (8950517800)
    ;
    Milutinović, Aleksandra Sokić (55956752600)
    ;
    Kovačević, Nada (7006810325)
    ;
    Radaljac, Tatjana (50262864800)
    ;
    Popović, Dragan (7201969148)
    ;
    Popović, Dušan Dj. (37028828200)
    ;
    Krstić, Miodrag (35341982900)
    Background/Aim. Primary biliary cirrhosis (PBC) is a progressive, chronic liver disease with elevated serum lipids, but it is unclear whether hyperlipidemia in PBC patients is associated with atherosclerosis. Metabolic syndrome promotes development of atherosclerotic cardiovascular disease related to abdominal type obesity and insulin resistance. The aim of our study was to assess abdominal adiposity in patients with PBC. Methods. The study included 40 patients with PBC and 50 healthy controls. Age, sex and anthropometric measurements (weight, height, body mass index and waist circumference) were registered for all patients and controls. We used ultrasonography to measure subcutaneous (SF) and visceral fat (VF) diameter, subcutaneous area (SA) and visceral area (VA), as well as perirenal fat diameter (PF). Results. Values of SF, VF and PF thicknesses in PBC patients were 19.23 ± 5.85 mm, 10.92 ± 3.63 mm, and 7.03 ± 1.82 mm, respectively. In controls these measurements were 22.73 ± 6.70 mm, 16.84 ± 5.51 mm and 10.50 ± 2.70 mm respectively. In PBC patients SA and VA were calculated to 983.64 ± 322.68 mm 2 and 403.64 ± 166.97 mm 2 and in controls 1124.89 ± 366.01 mm 2 and 720.57 ± 272.50 mm 2 respectrively. Significant difference was found for VF, VA and RF values. Conclusions. Considering that the amount of visceral fat plays an important role in development of metabolic syndrome and cardiovascular diseases, we concluded that the lower amount of visceral fat in PBC patients could be related to lower incidence of cardiovascular events, despite hyperlipidemia.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Visceral leishmaniasis in a patient with ulcerative colitis – A case report; [Visceralna lajšmanioza kod bolesnice sa ulceroznim kolitisom]
    (2020)
    Janković, Goran (7005387171)
    ;
    Martinović, Lena (54389514000)
    ;
    Dakić, Zorica (35186070500)
    ;
    Mijač, Dragana (16550439600)
    ;
    Štulić, Miloš (55895099100)
    ;
    Krstić, Miodrag (35341982900)
    Introduction. There is a rise of visceral leishmaniasis in immunocompromised patients due to increased availability of immunomodulatory drugs. In order to point at the occurrence of visceral leishmaniasis in patients with inflammatory bowel disease (IBD), we reported a case of female patient with a travel history to European Mediterranean countries, who was on immunosuppressive treatment due to ulcerative colitis. Case report. A 29-year-old female patient was admitted to hospital due to severe relapse of ulcerative colitis. Corticosteroid therapy was administered in addition to previous longterm azathioprine, with clinical response to the treatment. During the course of the disease she had recurrent high-grade fever with marked hepatosplenomegaly and pancytopenia. The diagnosis of leishmaniasis was established by positive serology tests and microscopic finding of amastigotes in bone marrow smears. The disseminated infection was responsive to treatment with liposomal amphotericin B, but therapy had to be discontinued due to urticarial rush. Subsequent therapy with antimony was administered, but it had to be stopped too due to liver toxicity. No further treatment for leishmaniasis was initiated as the clinical and laboratory data suggested that the patient had responded to the treatment. She was discharged from hospital in IBD remission and without signs of the infection. Conclusion. Visceral leishmaniasis should be considered in IBD patients with fever of unknown origin and relevant travel history in order to achieve favorable disease outcome. © 2020 Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback